Founder effect of a pathogenic MSH2 mutation identified in Spanish families with Lynch syndrome

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Genetics

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1399-0004.2009.01346.xPMID 20095990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Human Gene Mutation Database: 2008 update

  2009cited by this paper
• Mutations in the MECP2 Gene Are Not a Major Cause of Rett Syndrome-Like or Related Neurodevelopmental Phenotype in Male Patients

  2009cited by this paper
• Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance

  2009cited by this paper
• Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy

  2009cited by this paper
• Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching.

  2009cited by this paper
• Origins and prevalence of the American Founder Mutation of MSH2.

  2008cited by this paper
• MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

  2008cited by this paper
• A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome

  2008influential reference
• High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers

  2008cited by this paper
• The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside

  2007cited by this paper
• Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC

  2007cited by this paper
• A new variant database for mismatch repair genes associated with Lynch syndrome

  2007influential reference
• MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother.

  2007cited by this paper
• New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.

  2006cited by this paper
• Early progressive encephalopathy in boys and MECP2 mutations

  2006cited by this paper
• Male Rett Phenotypes in T158M and R294X MeCP2-mutations

  2006cited by this paper
• Recurrent Infections, Hypotonia, and Mental Retardation Caused by Duplication of MECP2 and Adjacent Region in Xq28

  2006cited by this paper
• X-inactivation profile reveals extensive variability in X-linked gene expression in females

  2005cited by this paper
• Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome

  2005cited by this paper
• Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

  2005cited by this paper
• Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.

  2005cited by this paper
• Germline PMS2 mutations: one hit or two?

  2005influential reference
• Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

  2005cited by this paper
• The Incidence of Lynch Syndrome

  2005cited by this paper
• MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.

  2004cited by this paper
• The Incidence of Lynch Syndrome

  2004influential reference
• A comparison of bayesian methods for haplotype reconstruction from population genotype data.

  2003cited by this paper
• RettBASE: The IRSA MECP2 variation database—a new mutation database in evolution

  2003cited by this paper
• Hereditary colorectal cancer.

  2003cited by this paper
• The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

  2002cited by this paper
• Recurrent germline mutation in MSH2arises frequently de novo

  2000cited by this paper
• Two affected boys in a Rett syndrome family

  2000cited by this paper
• A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer

  1999cited by this paper
• Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

  1999cited by this paper
• A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.

  1997cited by this paper
• A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome

  1995influential reference
• A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome.

  1995cited by this paper
• Genetic mapping of a locus predisposing to human colorectal cancer.

  1993cited by this paper
• Hereditary Colorectal Cancer

  1990influential reference

• Exonic splicing code and coordination of divalent metals in proteins

  2023cites this paper
• Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2 responsible for tuberous sclerosis complex

  2019cites this paper
• The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.

  2019cites this paper
• Characterization of a rare variant (c.2635-2A>G) of the MSH2 gene in a family with Lynch syndrome

  2018cites this paper
• Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome.

  2017cites this paper
• Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome

  2015cites this paper
• Identification of a founder EPCAM deletion in Spanish Lynch syndrome families

  2014cites this paper
• Mutation spectrum in South American Lynch syndrome families

  2013cites this paper
• Novel MLH1 duplication identified in Colombian families with Lynch syndrome

  2011cites this paper
• Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

  2011cites this paper
• MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.

  2010cites this paper